Professor Chris Goodnow has taken up the position of deputy director at the Garvan Institute of Medical Research. [ + ]

Avita Medical (ASX:AVH) has started recruiting for a phase III trial of ReCell in burn injuries, as part of its application process in the US and by extension the UK.

The British Council has opened the call for applications for FameLab 2015 - a competition for science, maths and engineering researchers with a determination to build their communication skills and make strong connections with others. [ + ]

The British Council has opened the call for applications for FameLab 2015 - a competition for science, maths and engineering researchers with a determination to build their communication skills and make strong connections with others. [ + ]

Sleep-disordered breathing technology company ResMed (ASX:RMD) has reported a 5% increase in profit and a 10% hike in revenue for the December quarter.

Amid the growing realisation that Australian research needs support to make it a reality, the Queensland Premier has pledged a "centrepiece" $90 million Research to Reality Fund if the LNP is returned in this weekend's election.

Evergreen private investment firm Manifex has opened of its second round of funding to help start-ups commercialise their high-tech products. Funding will be available to support companies that have developed technology in the advanced materials and advanced manufacturing sectors. [ + ]

Sienna Cancer Diagnostics CEO Dr Kerry Hegarty has resigned from the role after a 10-year term, as part of the company's strategic transformation plan.

Researchers from The Centenary Institute, Sydney, have announced a breakthrough in understanding the cause of stroke in young people. The leader of the research, Dr Xiangjian Zheng, said the stroke in question affects around five in every 1000 people, many of whom are diagnosed in their 30s and 40s. [ + ]

Troublesome jellyfish blooms may be better controlled by exploiting the finding that barrel jellyfish can detect the direction of ocean currents and swim strongly against them. [ + ]

Digital health is one of the strongest trends in healthcare and is transforming the delivery of healthcare around the world, including, but not limited to, digital applications (apps) and wearable technology. AusBiotech members are increasingly developing digital health technologies.

Professor Brendan Crabb, Professor John Funder and Professor Jeremy Chapman were awarded Companions of the Order of Australia in the Australia Day 2015 Honours List for their contributions to medicine.

Viralytics (ASX:VLA) has enrolled the first patient for a UK phase I trial of Cavatak in non-muscle invasive bladder cancer.

US biologists have proposed next-generation sequencing (NGS) as a way to provide fresh insight into populations' responses to a changing world. NGS, which makes it possible to analyse enormous numbers of short pieces of DNA very quickly, allows environmental biologists to assess the presence or absence of certain gene variants within local populations - which could point to selection for certain climate-adapted traits. [ + ]

Sigma-Aldrich's Research business unit has formed an alliance with VIB, a Belgium-based life science research institute, in a move that will focus on the commercialisation and supply of new tools and technologies to help meet the evolving needs of translational researchers. [ + ]